Mental health issues often plague people with diabetes – regardless of the type they have or where they are on their diabetes journey. Although these issues are now recognised by the medical world as a secondary complication of #diabetes, the connection between mental health and diabetes is still rarely discussed openly. It’s time to talk and listen to #VoicesOfDiabetes. Find out in this candid interview with Santiago Paulos about his secret weapons for protecting his mental well-being against the daily grind of diabetes management: http://spkl.io/6049fpL5v #ConnectingWhatCounts #WorldDiabetesDay #MentalHealth #DiabetesLife #VoicesOfDiabetes
Info
Roche ist ein globales Unternehmen mit Vorreiterrolle in der Erforschung und Entwicklung von Medikamenten und Diagnostika und ist darauf fokussiert, Menschen durch wissenschaftlichen Fortschritt ein besseres, längeres Leben zu ermöglichen. Dank der Kombination von Pharma und Diagnostika unter einem Dach ist Roche führend in der personalisierten Medizin - einer Strategie mit dem Ziel, jeder Patientin und jedem Patienten die bestmögliche Behandlung zukommen zu lassen. Roche ist das grösste Biotech-Unternehmen weltweit mit differenzierten Medikamenten für die Onkologie, Immunologie, Infektionskrankheiten, Augenheilkunde und Erkrankungen des Zentralnervensystems. Roche ist auch der bedeutendste Anbieter von In-vitro-Diagnostika und gewebebasierten Krebstests und ein Pionier im Diabetesmanagement. Seit der Gründung im Jahr 1896 erforscht Roche bessere Wege, um Krankheiten zu verhindern, zu erkennen und zu behandeln und leistet einen nachhaltigen Beitrag zur gesellschaftlichen Entwicklung. Zum Ziel des Unternehmens gehört es durch Kooperationen mit allen relevanten Partnern den Zugang von Patienten zu medizinischen Innovationen zu verbessern. Auf der Liste der unentbehrlichen Arzneimittel der Weltgesundheitsorganisation stehen heute 30 von Roche entwickelte Medikamente, darunter lebensrettende Antibiotika, Malariamittel und Krebsmedikamente. Ausgezeichnet wurde Roche zudem bereits das neunte Jahr in Folge als das nachhaltigste Unternehmen innerhalb der Pharma-, Biotechnologie- und Life-Sciences-Branche im Dow Jones Sustainability Index. Die Roche-Gruppe mit Hauptsitz in Basel, Schweiz ist in über 100 Ländern tätig und beschäftigte 2017 weltweit rund 94 000 Mitarbeiterinnen und Mitarbeiter. Im Jahr 2017 investierte Roche CHF 10,4 Milliarden in Forschung und Entwicklung und erzielte einen Umsatz von CHF 53,3 Milliarden. Genentech in den USA gehört vollständig zur Roche-Gruppe. Roche ist Mehrheitsaktionär von Chugai Pharmaceutical, Japan. Weitere Informationen finden Sie unter www.roche.com/careers #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- Website
-
http://www.roche.com/
Externer Link zu Roche
- Branche
- Biotechnologieforschung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Switzerland 🇨🇭
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- biotechnology, innovation, personalized healthcare, great place to work, diagnostics, pharmaceuticals, research, healthcare, personalised healthcare, diabetes care, genomics, healthcare technology, big data und Science
Orte
Beschäftigte von Roche
Updates
-
Ever wonder what happens when brilliant young minds are put in a glass cube for five days and thrown in a real-world healthcare challenge? To find out, Roche in Basel hosted one of the teams of the InCube Challenge from October 14 to 18. This partnership with ETH Zürich connects our company with forward-thinkers worldwide who look at complex problems with fresh perspectives.
-
🌍At Roche, we believe a healthier planet means healthier lives. Our commitment to sustainability drives us to protect the environment, expand access to healthcare, and ensure ethical, transparent operations worldwide. Through innovations in healthcare, responsible resource management, and ethical business practices, we’re advancing sustainable, long-term value for patients, communities, and the planet.🌿💙 Learn more 👉 https://lnkd.in/djUJ5YRT Read more about sustainability at Roche here 👉 https://lnkd.in/dRsJvW23
-
-
Why is it important to advocate for people with diabetes? Shelley Rogers Landes' story is a powerful reminder of how pervasive diabetes stigma still is— especially for people living with type 2 diabetes. But Shelley hasn’t given up. There are a number of ways to tackle stigma and discrimination, and they all start with just a little kindness. Thank you, Shelley' for being so open as you share your story with the world. Learn more how to be a diabetes ally: http://spkl.io/6040fTmjs #ConnectingWhatCounts #WorldDiabetesDay #MentalHealth #DiabetesLife #VoicesOfDiabetes
-
Did you know that the global economy loses significant amounts every minute due to the gender health gap? It’s time to uncover the true cost of neglecting women’s health. Stay tuned for crucial insights! #TogetherForChange #XIndex #XProject Find out more at: http://spkl.io/6049fTOhF
-
The power of partnerships can transform healthcare and give us all more time with the people we love. Through collaboration with Algerian health authorities, we're paving the way for early detection and innovative treatment for breast cancer. As a mother diagnosed with breast cancer, Karima's story is a testament to the impact we can make when we work together. Join us in making a difference and creating a healthier future for women everywhere. Find out more at: http://spkl.io/6043frXoL
-
Thank you, Kyle Srinivasan, for sharing the great news that Roche has again been voted number one in the PatientView Corporate Reputation of Pharma breast cancer survey. Partnering with patient communities is so important to the work we do, and this recognition reflects that. Congratulations to the teams involved! #PatientCommunity #PatientEngagement #BreastCancer
Collaborating with the global breast cancer community to strategically advise on how to humanize healthcare in the interest of people living with breast cancer
I am proud to share that, for the second time in a row, the Roche group was voted number one in the PatientView Corporate Reputation of Pharma breast cancer survey, published earlier this year! Voted by patient groups, in areas of importance defined by them, this achievement reflects the value and impact of our work with the breast cancer patient community. Our commitment to working with patients is deeply rooted in our company philosophy of everything we do for patients, we do with patients, every step of the way. To have our efforts in breast cancer recognized by patient groups who know us or work with us, is incredibly uplifting. We have an ambitious vision for the future in breast cancer – that no one dies of this disease. Continuing to make progress towards this would not be possible without our partnerships with patient groups. The valuable insights they provide help guide our R&D and allow us to identify areas we can provide tailored support. I want to recognize the important contributions of the Roche breast cancer team, and, most of all, extend our thanks to all our patient and patient group partners for their continued collaboration. Annunziata Menna, Cammy Cheung Cláudia Echeverria Emilie Prazakova Esnath Muzenda Gaurav Jain Gunita Mitera Halima Okafor Jacqueline Wambua Lauren Davis Pariani Maria Julia Alves Batista Mona Van Steenberghe Naziah Lasi-Tejani Niki Ben Simon Noa Katz Sanjana Misra Poul Riese Eliyahu-Melamed Rachel Rebecca V. Spela (Mancek) Lalic Stefanie Klein
-
-
We are thrilled to announce that our pRED Innovation Center in Basel has been awarded by SEFA Labs the “SEFA Lab of the Year Award 2024”! 🏆 Presented annually by a jury of experts, the award recognizes the project team behind the most outstanding laboratory building. This is an incredible achievement for Roche and the project team, including the specialist planners and architects who brought this vision to life. Read more about it here: https://www.sefalabs.com/ A heartfelt thank you to everyone for making this happen! Geo Adam, Achim Grenz, Katrin Arnold, Werner Pietzonka, Marcus Hablützel, Ulrich Prutscher, Paul Kath, Markus von Grünigen, Dario Tonelli, Thore-Philipp Kuhn and Stefan Baumgartner #Winner #SEFA #Award #Lab #LaboftheYear
-
At Roche, our goal in breast cancer is to relentlessly pursue a cure. We’re focusing on three key areas of unmet needs – minimising the risk of the disease returning in early-stages, overcoming resistance to treatment, and reducing the risk of the cancer spreading to the brain. In our latest ‘Cancer Dialogue’ episode, Roche-Genentech’s Maura Dickler and expert Professor Peter Fasching met to talk about unmet needs, current and future focus areas. 👉 http://spkl.io/6049fON5x
-
👥 Where diversity thrives, people thrive. By embedding Diversity, Equity, and Inclusion into our daily practices, we empower everyone to bring their authentic selves to work. Through our Diversity Networks and inclusion initiatives, we foster a culture where collaboration, innovation, and wellbeing flourish. ✨ We believe that a workplace that embraces diversity leads to a healthier, more engaged team. 🤝 Want to learn more about our commitment to inclusion? Learn more ➡️ https://lnkd.in/dXk43hKC
-
Verbundene Seiten
Ähnliche Seiten
Finanzierung
Roche
Insgesamt 4 Finanzierungsrunden
![]()
SoftBank
Weitere Informationen auf Crunchbase
Letzte Runde
Kapitalerhöhung nach Börsengang
Externer Crunchbase-Link für die letzte Finanzierungsrunde
5.000.000.000,00 $
Investor:innen